Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)

Angela Joubert James; Catherine C. Smith; Mark Litzow; Alexander E. Perl; Jessica K. Altman; Dale Shepard; Takeshi Kadokura; Kinya Souda; Melanie Patton; Zheng Lu; Chaofeng Liu; Selina Moy; Mark J. Levis; Erkut Bahceci

doi:10.1007/s40262-021-01060-8

Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)

Angela Joubert James^*, Catherine C. Smith, Mark Litzow, Alexander E. Perl, Jessica K. Altman, Dale Shepard, Takeshi Kadokura, Kinya Souda, Melanie Patton, Zheng Lu, Chaofeng Liu, Selina Moy, Mark J. Levis, Erkut Bahceci

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In Table 8 of this article, the data in the column headed “Fed Geometric LS Mean” were mistakenly listed under column heading “Fasted Geometric LS Mean”and vice versa. The correct Table 8 is as follows: (Table presented.).

Original language	English (US)
Pages (from-to)	1251
Number of pages	1
Journal	Clinical Pharmacokinetics
Volume	60
Issue number	9
DOIs	https://doi.org/10.1007/s40262-021-01060-8
State	Published - Sep 2021

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1007/s40262-021-01060-8

Cite this

James, A. J., Smith, C. C., Litzow, M., Perl, A. E., Altman, J. K., Shepard, D., Kadokura, T., Souda, K., Patton, M., Lu, Z., Liu, C., Moy, S., Levis, M. J., & Bahceci, E. (2021). Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w). Clinical Pharmacokinetics, 60(9), 1251. https://doi.org/10.1007/s40262-021-01060-8

@article{f03b90c9de66497ba3a72a7d98679253,

title = "Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)",

abstract = "In Table 8 of this article, the data in the column headed “Fed Geometric LS Mean” were mistakenly listed under column heading “Fasted Geometric LS Mean”and vice versa. The correct Table 8 is as follows: (Table presented.).",

author = "James, {Angela Joubert} and Smith, {Catherine C.} and Mark Litzow and Perl, {Alexander E.} and Altman, {Jessica K.} and Dale Shepard and Takeshi Kadokura and Kinya Souda and Melanie Patton and Zheng Lu and Chaofeng Liu and Selina Moy and Levis, {Mark J.} and Erkut Bahceci",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021",

year = "2021",

month = sep,

doi = "10.1007/s40262-021-01060-8",

language = "English (US)",

volume = "60",

pages = "1251",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis",

number = "9",

}

James, AJ, Smith, CC, Litzow, M, Perl, AE, Altman, JK, Shepard, D, Kadokura, T, Souda, K, Patton, M, Lu, Z, Liu, C, Moy, S, Levis, MJ & Bahceci, E 2021, 'Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)', Clinical Pharmacokinetics, vol. 60, no. 9, pp. 1251. https://doi.org/10.1007/s40262-021-01060-8

Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w). / James, Angela Joubert; Smith, Catherine C.; Litzow, Mark et al.
In: Clinical Pharmacokinetics, Vol. 60, No. 9, 09.2021, p. 1251.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)

AU - James, Angela Joubert

AU - Smith, Catherine C.

AU - Litzow, Mark

AU - Perl, Alexander E.

AU - Altman, Jessica K.

AU - Shepard, Dale

AU - Kadokura, Takeshi

AU - Souda, Kinya

AU - Patton, Melanie

AU - Lu, Zheng

AU - Liu, Chaofeng

AU - Moy, Selina

AU - Levis, Mark J.

AU - Bahceci, Erkut

PY - 2021/9

Y1 - 2021/9

N2 - In Table 8 of this article, the data in the column headed “Fed Geometric LS Mean” were mistakenly listed under column heading “Fasted Geometric LS Mean”and vice versa. The correct Table 8 is as follows: (Table presented.).

AB - In Table 8 of this article, the data in the column headed “Fed Geometric LS Mean” were mistakenly listed under column heading “Fasted Geometric LS Mean”and vice versa. The correct Table 8 is as follows: (Table presented.).

UR - http://www.scopus.com/inward/record.url?scp=85111133190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111133190&partnerID=8YFLogxK

U2 - 10.1007/s40262-021-01060-8

DO - 10.1007/s40262-021-01060-8

M3 - Comment/debate

C2 - 34297319

AN - SCOPUS:85111133190

SN - 0312-5963

VL - 60

SP - 1251

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 9

ER -

Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor (Clinical Pharmacokinetics, (2020), 59, 10, (1273-1290), 10.1007/s40262-020-00888-w)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this